UEMS Medicinsk speciale

Psykiatri & Neurodevelopment — Side 2

Formulation science addressing mental health: catecholaminergic modulation, ADHD, mood disorders, neuropsychological function, and the gut–brain axis as a therapeutic target.

25

dossierer

Præcisionsmikrobiom & Tarm-hjerne-aksen

Tarm-hjerne-aksen ved ADHD: Mikrobiota-medieret modulering af den dopaminerge signalvej

Udvikling af videnskabeligt validerede mikrobiom-målrettede interventioner til ADHD indebærer håndtering af udfordringer vedrørende heterogenitet i kliniske resultater og identifikation af præcise mikrobielle mekanismer. Formulering af stabile, effektive probiotika eller synbiotika med påviste kliniske fordele forbliver en væsentlig barriere.

NeuroinflammationAttention Deficit Disorder with HyperactivityDopamineSerotonin

Skræddersyet formulering tilgængelig

Har du brug for et dossier til dit molekyle?

Project-specific requirements and next steps are confirmed in writing through the agreed scope.

Request a written scoped quote← Vend tilbage til Clinical Matrix

RELATED RESOURCES

R&D Hub — All Scientific CategoriesFull library of evidence-based research covering formulation, bioavailability and clinical nutrition.EXPLORE ›Advanced Formulation Technology PlatformProject-specific formulation assessment, evidence review and regulatory pathway are defined in the agreed scope. Manufacturing arrangements and any external testing are confirmed per project.EXPLORE ›Production Formats & MOQ ReferenceHard capsules 150K, softgels 300K, sachets 75K — connect the science to actual industrial thresholds.EXPLORE ›Physician Supplement Brand Contract ManufacturingA project brief defines the formulation, evidence, regulatory path, scope and ownership terms before manufacturing is considered.EXPLORE ›Paid Discovery: R&D Due Diligence EntryTransform research findings into a scoped, confidential manufacturing brief.EXPLORE ›Commercialization Intelligence HubRegulatory and market strategy intelligence for supplement brand decision-makers.EXPLORE ›